David Sperandio

968 total citations
22 papers, 581 citations indexed

About

David Sperandio is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, David Sperandio has authored 22 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Immunology. Recurrent topics in David Sperandio's work include Mast cells and histamine (5 papers), Synthesis and Properties of Aromatic Compounds (3 papers) and Peptidase Inhibition and Analysis (3 papers). David Sperandio is often cited by papers focused on Mast cells and histamine (5 papers), Synthesis and Properties of Aromatic Compounds (3 papers) and Peptidase Inhibition and Analysis (3 papers). David Sperandio collaborates with scholars based in United States, Switzerland and New Zealand. David Sperandio's co-authors include Paul A. Wender, Emma Shelton, Joane Litvak, Anthony R. Gangloff, Kenneth D. Rice, Hans‐Jürǵen Hansen, Mary E. McGrath, Paul A. Sprengeler, Jeffrey R. Spencer and John R. Somoza and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Biochemistry.

In The Last Decade

David Sperandio

22 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sperandio United States 13 336 194 63 53 38 22 581
Girija Krishnamurthy United States 18 355 1.1× 432 2.2× 79 1.3× 85 1.6× 68 1.8× 30 867
Dominique Bridon United States 18 352 1.0× 338 1.7× 74 1.2× 44 0.8× 99 2.6× 29 966
Guillermo A. Morales United States 18 598 1.8× 551 2.8× 55 0.9× 27 0.5× 68 1.8× 26 1.0k
Luc J. Farmer United States 14 227 0.7× 160 0.8× 30 0.5× 25 0.5× 60 1.6× 25 602
John J. Court United States 13 298 0.9× 151 0.8× 45 0.7× 25 0.5× 46 1.2× 20 430
David A. Betebenner United States 15 348 1.0× 368 1.9× 195 3.1× 49 0.9× 94 2.5× 23 800
Eliška Procházková Czechia 16 222 0.7× 285 1.5× 82 1.3× 62 1.2× 25 0.7× 60 702
Masahiro Fuji Japan 13 607 1.8× 267 1.4× 136 2.2× 41 0.8× 110 2.9× 22 949
Chris Phillips United Kingdom 15 217 0.6× 700 3.6× 103 1.6× 40 0.8× 98 2.6× 20 983
Rajeshri G. Karki United States 17 299 0.9× 420 2.2× 283 4.5× 48 0.9× 62 1.6× 25 778

Countries citing papers authored by David Sperandio

Since Specialization
Citations

This map shows the geographic impact of David Sperandio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sperandio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sperandio more than expected).

Fields of papers citing papers by David Sperandio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sperandio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sperandio. The network helps show where David Sperandio may publish in the future.

Co-authorship network of co-authors of David Sperandio

This figure shows the co-authorship network connecting the top 25 collaborators of David Sperandio. A scholar is included among the top collaborators of David Sperandio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sperandio. David Sperandio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Jason Z., Guoqing Wang, Vivian Zhang, et al.. (2023). Abstract 4976: Preclinical characterization of BGI-9004, a covalent TEAD inhibitor with exceptional anti-cancer activity and combination potential. Cancer Research. 83(7_Supplement). 4976–4976. 3 indexed citations
2.
Nguyen, Thomas T., Ulhas Bhatt, Kevin Li, et al.. (2023). Novel series of tunable µOR modulators with enhanced brain penetration for the treatment of opioid use disorder, pain and neuropsychiatric indications. Bioorganic & Medicinal Chemistry Letters. 92. 129405–129405. 1 indexed citations
3.
Law, Brian K., Tenley C. Archer, Daniel Lu, et al.. (2022). Bmf-500: An Orally Bioavailable Covalent Inhibitor of FLT3 with High Selectivity and Potent Antileukemic Activity in FLT3-Mutated AML. Blood. 140(Supplement 1). 6191–6192. 3 indexed citations
4.
Ranjbarvaziri, Sara, Farshad Farshidfar, Jaclyn J. Ho, et al.. (2022). Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy. Science Translational Medicine. 14(652). eabl5654–eabl5654. 25 indexed citations
5.
Shi, Xiarong, Valia T. Mihaylova, Leena Kuruvilla, et al.. (2016). Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β–dependent mechanisms. Proceedings of the National Academy of Sciences. 113(31). E4558–66. 30 indexed citations
6.
Samuel, Dharmaraj, Weimei Xing, Anita Niedziela‐Majka, et al.. (2015). GS-5806 Inhibits Pre- to Postfusion Conformational Changes of the Respiratory Syncytial Virus Fusion Protein. Antimicrobial Agents and Chemotherapy. 59(11). 7109–7112. 33 indexed citations
7.
Boojamra, Constantine G., Jay P. Parrish, David Sperandio, et al.. (2008). Design, synthesis, and anti-HIV activity of 4′-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry. 17(4). 1739–1746. 43 indexed citations
8.
Drewe, John, Shailaja Kasibhatla, Ben Tseng, et al.. (2007). Discovery of 5-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-7-phenyl-(E)-2,3,6,7-tetrahydro-1,4-thiazepines as a new series of apoptosis inducers using a cell- and caspase-based HTS assay. Bioorganic & Medicinal Chemistry Letters. 17(17). 4987–4990. 15 indexed citations
9.
Dener, Jeffrey M., Daniel A. Dickman, Paul G. Grothaus, et al.. (2006). Identification of metabolites of the tryptase inhibitor CRA-9249: Observation of a metabolite derived from an unexpected hydroxylation pathway. Bioorganic & Medicinal Chemistry Letters. 16(15). 4053–4058. 4 indexed citations
10.
Lee, Chang-Sun, Weili Liu, Paul A. Sprengeler, et al.. (2006). Design of novel, potent, and selective human β-tryptase inhibitors based on α-keto-[1,2,4]-oxadiazoles. Bioorganic & Medicinal Chemistry Letters. 16(15). 4036–4040. 11 indexed citations
11.
Sperandio, David, Vincent W.‐F. Tai, Julia Lohman, et al.. (2006). Novel, potent, selective, and orally bioavailable human βII-tryptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(15). 4085–4089. 9 indexed citations
12.
Palmer, James T., Robert M. Rydzewski, Rohan Mendonca, et al.. (2006). Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(13). 3434–3439. 17 indexed citations
13.
Somoza, John R., Joseph D. Ho, Christine Luong, et al.. (2003). The Structure of the Extracellular Region of Human Hepsin Reveals a Serine Protease Domain and a Novel Scavenger Receptor Cysteine-Rich (SRCR) Domain. Structure. 11(9). 1123–1131. 66 indexed citations
14.
Sperandio, David, Anthony R. Gangloff, Joane Litvak, et al.. (2002). Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease. Bioorganic & Medicinal Chemistry Letters. 12(21). 3129–3133. 29 indexed citations
15.
Gangloff, Anthony R., et al.. (2001). Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst. Tetrahedron Letters. 42(8). 1441–1443. 110 indexed citations
16.
Wender, Paul A. & David Sperandio. (1998). A New and Selective Catalyst for the [5 + 2] Cycloaddition of Vinylcyclopropanes and Alkynes. The Journal of Organic Chemistry. 63(13). 4164–4165. 94 indexed citations
17.
Koźmiński, Wiktor, David Sperandio, & Daniel Nanz. (1996). Sensitive Measurement of One-Bond Carbon-Carbon Spin Coupling Constants at Natural Isotope Abundance. Magnetic Resonance in Chemistry. 34(4). 311–315. 13 indexed citations
18.
Bühl, Michæl, Wiktor Koźmiński, Anthony Linden, et al.. (1996). An Analysis of the Bonding Properties of Benz[a]azulene by X‐Ray, NMR, and Computational Studies. Helvetica Chimica Acta. 79(3). 837–854. 11 indexed citations
19.
Sperandio, David & Hans‐Jürǵen Hansen. (1995). An Efficient Straightforward Synthesis of Benz[a]azulene. Helvetica Chimica Acta. 78(3). 765–771. 25 indexed citations
20.
Sperandio, David, et al.. (1995). Thermal Reaction of Azulenes with Dimethyl Acetylenedicarboxylate in Supercritical Carbon Dioxide. Helvetica Chimica Acta. 78(3). 772–777. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Girija Krishnamurthy Breakdown of academic impact, for papers by Dominique Bridon Breakdown of academic impact, for papers by Guillermo A. Morales Breakdown of academic impact, for papers by Luc J. Farmer Breakdown of academic impact, for papers by John J. Court Breakdown of academic impact, for papers by David A. Betebenner Breakdown of academic impact, for papers by Eliška Procházková Breakdown of academic impact, for papers by Masahiro Fuji Breakdown of academic impact, for papers by Chris Phillips Breakdown of academic impact, for papers by Rajeshri G. Karki
Rankless by CCL
2026